1. Home
  2. Labeler Index
  3. Bayer Healthcare Llc.
  4. 0280-0023
  5. NDC Package Code: 0280-0023-02 Alka-seltzer Plus Severe Cold And Cough Powerfast Fizz

NDC Package 0280-0023-02 Alka-seltzer Plus Severe Cold And Cough Powerfast Fizz

Aspirin,Chlorpheniramine Maleate,Dextromethorphan Hydrobromide,Phenylephrine Bitartrate - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0280-0023-02
Package Description:
24 POUCH in 1 CARTON / 2 TABLET, EFFERVESCENT in 1 POUCH
Product Code:
0280-0023
Proprietary Name:
Alka-seltzer Plus Severe Cold And Cough Powerfast Fizz
Non-Proprietary Name:
Aspirin, Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, Phenylephrine Bitartrate
Substance Name:
Aspirin; Chlorpheniramine Maleate; Dextromethorphan Hydrobromide; Phenylephrine Bitartrate
Usage Information:
Directions● adults and children 12 years and over: take 2 tablets fully dissolved in 4 oz of water every 4 hours. Do not exceed 8 tablets in 24 hours or as directed by a doctor.● children under 12 years: do not use
11-Digit NDC Billing Format:
00280002302
NDC to RxNorm Crosswalk:
  • RxCUI: 1537029 - aspirin 325 MG / chlorpheniramine maleate 2 MG / dextromethorphan HBr 10 MG / phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet
  • RxCUI: 1537029 - aspirin 325 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG / phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet
  • RxCUI: 1537029 - ASA 325 MG / Chlorpheniramine Maleate 2 MG / Dextromethorphan Hydrobromide 10 MG / Phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet
    • Product Type:
    Human Otc Drug
    Labeler Name:
    Bayer Healthcare Llc.
    Dosage Form:
    Tablet, Effervescent - A solid dosage form containing mixtures of acids (e.g., citric acid, tartaric acid) and sodium bicarbonate, which release carbon dioxide when dissolved in water; it is intended to be dissolved or dispersed in water before administration.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • ASPIRIN 325 mg/1
  • CHLORPHENIRAMINE MALEATE 2 mg/1
  • DEXTROMETHORPHAN HYDROBROMIDE 10 mg/1
  • PHENYLEPHRINE BITARTRATE 7.8 mg/1
    • Pharmacologic Class(es):
  • Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
  • Anti-Inflammatory Agents, Non-Steroidal - [CS]
  • Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
  • Decreased Platelet Aggregation - [PE] (Physiologic Effect)
  • Decreased Prostaglandin Production - [PE] (Physiologic Effect)
  • Histamine H1 Receptor Antagonists - [MoA] (Mechanism of Action)
  • Histamine-1 Receptor Antagonist - [EPC] (Established Pharmacologic Class)
  • Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
  • Platelet Aggregation Inhibitor - [EPC] (Established Pharmacologic Class)
  • Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
  • Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
  • Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
  • Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
  • alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    part341
    Marketing Category:
    OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
    Start Marketing Date:
    04-01-2020
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    0280-0023-0110 POUCH in 1 CARTON / 2 TABLET, EFFERVESCENT in 1 POUCH
    0280-0023-0312 POUCH in 1 CARTON / 2 TABLET, EFFERVESCENT in 1 POUCH

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0280-0023-02?

    The NDC Packaged Code 0280-0023-02 is assigned to a package of 24 pouch in 1 carton / 2 tablet, effervescent in 1 pouch of Alka-seltzer Plus Severe Cold And Cough Powerfast Fizz, a human over the counter drug labeled by Bayer Healthcare Llc.. The product's dosage form is tablet, effervescent and is administered via oral form.

    Is NDC 0280-0023 included in the NDC Directory?

    Yes, Alka-seltzer Plus Severe Cold And Cough Powerfast Fizz with product code 0280-0023 is active and included in the NDC Directory. The product was first marketed by Bayer Healthcare Llc. on April 01, 2020 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 0280-0023-02?

    The 11-digit format is 00280002302. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20280-0023-025-4-200280-0023-02